Teleflex shares (NYSE:TFX) took a hit this morning after the medical device maker missed Wall Street’s profit expectations, despite raising both its top and bottom lines.
The Limerick, Pa.-based company reported profits of $167.8 million, or $1.02 per diluted share, on sales of $411.7 million during the 3 months ended Dec. 31, 2011. That’s a bottom-line gain of 107% and a top-line addition of 6.6%, compared with profits of $81.1 million, or 33 cents diluted EPS, on sales of $386.3 million for Q4 2010.